The nausea typically begins shortly after taking the injection and can last for several hours, especially if taken on an empty stomach
As required by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) 12,13,14,15 , and to extend the safety evaluation in a broader population with T2D, the tirzepatide clinical development program for treatment of T2D (SURPASS) was also designed to evaluate the drugs cardiovascular safety in people with T2D at low, medium and high cardiovascular risk 12
Interpretation The benefit of GLP-1 RAs exceeded the harms for weight loss in the first 2 years of treatment, yet the net benefit was dependent on individual treatment goals (10% or 5% weight loss) and willingness to accept harms in pursuit of weight loss
Long-term continuation at a maintenance dose is the standard medical recommendation for sustaining weight loss achieved with GLP-1 therapy
Its rapidly metabolized and eliminated, which means most standard turmeric supplements deliver far less than the label suggests
